YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Serevent
Study Cites Increased Death Risk From Asthma Drugs
Jun 6, 2006 | Washington Post
Popular and long-acting asthma medicines such as Advair and Serevent pose a substantially increased risk of hospitalization and death to users...
Advair, Other Asthma Drug Get Label Alerts
Mar 6, 2006 | AP
The asthma medication Advair and a related drug will bear stronger warnings of an increased risk of death associated with one of their...
Top Asthma Drugs Get Stronger Warning
Mar 6, 2006 | KTLA News
The asthma medication Advair and Serevent will now carry the strongest warnings the FDA can require of prescription drugs.The "black-box"...
Serevent Exposes Blacks to Higher Risk of Asthma-Related Death Study
Feb 22, 2006 | Newsinferno News Staff
A new study has found that GlaxoSmithKline’s (GSK) popular asthma drug, Serevent, (salmeterol), exposes African-American patients to a higher...
Serevent May Pose Greater Risk of Death to Blacks
Jan 13, 2006 | Newsinferno News Staff
Recently released information about a safety trial on the asthma drug Serevent indicates that blacks who took the drug were four times as likely to...
Asthma Drugs Educe FDA Worry
Nov 18, 2005 | www.thestreet.com
The Food and Drug Administration on Friday issued a public health advisory about potentially fatal side effects from two GlaxoSmithKline asthma...
Serevent, Advair, and Foradil Linked to Risk of Severe Asthma Exacerbations, Death
Nov 18, 2005 | Medscape
The U.S. Food and Drug Administration (FDA) has warned healthcare professionals regarding the increased risk of severe asthma episodes and death...
Safety Information About A Class of Asthma Drugs Known As Long-Acting Beta-2 Agonists
Oct 4, 2005 | Health Canada
Health Canada is advising Canadians of the possible increased risks of asthma-related deaths associated with the use of a class of asthma drugs known...
Serevent, To Be Examined By Experts Due To Deaths Associated With Its Use
Jul 17, 2005
Serevent, a powdered medication inhaled by asthma patients to keep their airways open, will be a focus of an FDA Pulmonary-Allergy Drugs Advisory...
FDA Orders "Black Box" Warning for Asthma Drugs
Jul 14, 2005 | www.consumeraffairs.com
The US Food and Drug Administration has cleared asthma drugs Advair and Serevent, allowing them to stay on the market as long as warning labels...
Serevent
